Artificial Intelligence Clinical Genomics Interpretation Market Report 2026

Artificial Intelligence Clinical Genomics Interpretation Market Overview

• Artificial Intelligence Clinical Genomics Interpretation market size has reached to $1.74 billion in 2025 • Expected to grow to $5.99 billion in 2030 at a compound annual growth rate (CAGR) of 28% • Growth Driver: Surge In Demand For Personalized Medicine Fueling The Growth Of The Market Due To More Effective, Patient-specific Treatments • Market Trend: Qiagen Launches Advanced AI Tool To Streamline Biological Data Analysis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Artificial Intelligence Clinical Genomics Interpretation Market?

Artificial intelligence clinical genomics interpretation refers to the use of artificial intelligence-driven algorithms and computational models to analyze and interpret genomic data for clinical applications. It enables the identification of genetic variants, prediction of disease risk, and guidance for personalized treatment decisions. The main components of artificial intelligence (AI) clinical genomics interpretation are software and services. The software includes AI-driven platforms and applications designed for automated analysis, interpretation, and reporting of complex clinical genomic data. These solutions can be deployed in cloud-based or on-premises environments. Applications span oncology, rare diseases, pharmacogenomics, infectious diseases, and more, while key end users include hospitals and clinics, research institutes, diagnostic laboratories, and other organizations involved in clinical genomics.

What Is The Artificial Intelligence Clinical Genomics Interpretation Market Growth Forecast?

The artificial intelligence clinical genomics interpretation market size is expected to see exponential growth in the next few years. It will grow to $5.99 billion in 2030 at a compound annual growth rate (CAGR) of 28.0%. The growth in the forecast period can be attributed to increasing demand for personalized healthcare solutions, rising investments in genomic data analytics, expansion of oncology-focused genomics applications, growing adoption of cloud-based interpretation platforms, increasing focus on clinical-grade genomic reporting. Major trends in the forecast period include increasing adoption of AI-based variant interpretation tools, rising integration of genomics with clinical decision support, growing use of predictive modeling in genomic analysis, expansion of cloud-based genomics platforms, enhanced focus on personalized treatment planning.

Global Artificial Intelligence Clinical Genomics Interpretation Market Segmentation

1) By Component: Software, Services 2) By Deployment Mode: Cloud Based, On Premises 3) By Application: Oncology, Rare Diseases, Pharmacogenomics, Infectious Diseases, Other Applications 4) By End User: Hospitals And Clinics, Research Institutes, Diagnostic Laboratories, Other End User Subsegments: 1) By Software: Genomic Data Analysis, Variant Interpretation, Clinical Decision Support, Predictive Modeling, Reporting And Visualization 2) By Services: Implementation And Integration, Consulting And Advisory, Training And Support, Data Management, Maintenance And Upgrades

What Is The Driver Of The Artificial Intelligence Clinical Genomics Interpretation Market?

The rising demand for personalized medicine is expected to propel the growth of the artificial intelligence clinical genomics interpretation market going forward. Personalized medicine refers to a medical approach that tailors diagnosis, treatment, and prevention strategies to an individual’s genetic, environmental, and lifestyle factors. The increase in demand for personalized medicine is due to more effective treatments, as therapies are tailored to an individual’s genetic profile, improving outcomes and reducing adverse effects. Artificial intelligence clinical genomics interpretation helps drive demand for personalized medicine by rapidly analyzing complex genomic data to identify precise, patient-specific treatment options, improving therapy effectiveness, and reducing trial-and-error approaches. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the U.S. Food and Drug Administration (FDA) approved 16 new personalized treatments for patients with rare diseases, a significant increase from the six approved in 2022. Therefore, the rising demand for personalized medicine is expected to drive the growth of the artificial intelligence clinical genomics interpretation industry.

Key Players In The Global Artificial Intelligence Clinical Genomics Interpretation Market

Major companies operating in the artificial intelligence clinical genomics interpretation market are F. Hoffmann-La Roche AG, NVIDIA Corporation, Illumina Inc., QIAGEN N.V., Tempus Labs Inc., GeneDx Inc., Freenome Inc., NantHealth Inc., SOPHiA GENETICS SA, Genomenon Inc., DNAnexus Inc., Lifebit Biotech Ltd., Deep Genomics Inc., SpeeDx Pty Ltd, PierianDx Inc., Genuity Science Inc., Karius Inc., FDNA Inc., SeqOne Genomics Inc., Nostos Genomics Inc.

Global Artificial Intelligence Clinical Genomics Interpretation Market Trends and Insights

Major companies in the artificial intelligence clinical genomics interpretation market are focusing on innovations that enhance scalability for large genomic studies, enabling high-throughput data processing, improved accuracy of genomic insights, and faster discovery of biomarkers and therapeutic targets. Scalability refers to the capacity of AI systems to efficiently analyze massive and complex genomic datasets without compromising speed or precision, a critical requirement as sequencing volume and complexity continue to grow. For instance, in December 2024, QIAGEN, a Germany-based life sciences company, launched an AI-powered extension for its Ingenuity Pathway Analysis (IPA) platform to automate the interpretation of complex biological data. The enhancement uses AI to identify key genes, pathways, and molecular networks involved in diseases, and integrates QIAGEN’s Biomedical Knowledge Base containing hundreds of millions of AI-derived relationships to support more accurate and data-driven insights.

What Are Latest Mergers And Acquisitions In The Artificial Intelligence Clinical Genomics Interpretation Market?

In May 2025, GeneDx, a US-based provider of genomic diagnostic testing and precision medicine solutions, acquired Fabric Genomics for an undisclosed amount. With this acquisition, GeneDx aims to strengthen its artificial intelligence driven clinical genomics interpretation capabilities, particularly in rare diseases and neonatal genetic screening, thereby expanding its technological edge in precision medicine. Fabric Genomics is a US-based provider of AI-powered genomic data interpretation software and clinical decision support tools for healthcare providers and laboratories.

Regional Outlook

North America was the largest region in the artificial intelligence clinical genomics interpretation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Artificial Intelligence Clinical Genomics Interpretation Market?

The artificial intelligence clinical genomics interpretation market includes of revenues earned by entities by providing services such as variant interpretation services, pharmacogenomics interpretation services, and tumor genomic profiling services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Artificial Intelligence Clinical Genomics Interpretation Market Report 2026?

The artificial intelligence clinical genomics interpretation market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence clinical genomics interpretation industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.